Sign In
Buy LXRX
$2.31
-0.0300 (-1.28%)
At Close: Jul 31, 2026
Why Lexicon Pharmaceuticals Stock Crashed This Week
09:21am, Friday, 02'nd Jun 2023
With a new heart failure drug in hand, Lexicon Pharmaceuticals decided to raise capital this week, causing its shares to fall by double digits. The company plans on using the funds to support Inpefa's
Lexicon's (LXRX) Heart Failure Drug Inpefa Gets FDA Approval
12:10pm, Tuesday, 30'th May 2023
Lexicon's (LXRX) shares rise as it receives FDA approval for Inpefa, a once-daily oral tablet to treat a broad population of heart failure patients.
U.S. FDA approves Lexicon Pharma's heart failure drug
04:14pm, Friday, 26'th May 2023
The U.S. Food and Drug Administration (FDA) has approved Lexicon Pharmaceuticals Inc's drug as a broad treatment for all heart failure patients, including adults with type 2 diabetes, the company said
Wall Street's Counting on an FDA Nod for This Growth Stock to Nearly Double, but Should You?
06:50am, Thursday, 11'th May 2023
Lexicon's flagship medicine will go before regulators this month. There's a lot riding on getting an approval because it's running a bit low on cash.
Lexicon Pharmaceuticals to Host First Quarter 2023 Financial Results Conference Call and Webcast on May 2, 2023
04:00pm, Friday, 28'th Apr 2023
THE WOODLANDS, Texas, April 28, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) will release its first quarter 2023 financial results on Tuesday, May 2, 2023 after the markets cl
Should You Buy This Growth Stock Right Now Before It Potentially Doubles?
08:15am, Saturday, 22'nd Apr 2023
Lexicon is awaiting word from regulators about what could be its first product. Previously, regulators rejected its attempts to commercialize a similar program.
THE WOODLANDS Texas, April 21, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc . (Nasdaq: LXRX), today announced that results from RELIEF-PHN-1, a Phase 2 double-blind, placebo-controlled trial
Lexicon Pharmaceuticals to Host Fourth Quarter 2022 Financial Results Conference Call and Webcast on March 2, 2023
05:00pm, Tuesday, 28'th Feb 2023
THE WOODLANDS, Texas, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will release its fourth quarter 2022 financial results on Thursday, March 2, 2023 after the market
Nothing Ever Comes Easy For Lexicon, But Maybe Sotagliflozin Will Prevail In Heart Failure
08:00am, Sunday, 25'th Dec 2022
I discuss Lexicon's long and tumultuous history. Sotagliflozin has a PDUFA in May 2023 for a heart failure indication.
Lexicon Pharmaceuticals, Inc. (LXRX) Q3 2022 Earnings Call Transcript
09:34pm, Wednesday, 09'th Nov 2022
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX ) Q3 2022 Earnings Conference Call November 9, 2022 5:00 PM ET Company Participants Mike Kelly – Investor Relations Lonnel Coats – Chief Executive Office
Lexicon Pharmaceuticals to Host Third Quarter 2022 Financial Results Conference Call and Webcast on November 9, 2022
08:58am, Friday, 04'th Nov 2022
THE WOODLANDS, Texas, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will release its third quarter 2022 financial results on Wednesday, November 9, 2022, after the ma
5 Penny Stocks To Buy For Under $5
11:23am, Friday, 12'th Aug 2022
Hot penny stocks to watch or buy for under $5? Here's a list of .penny stocks gaining momentum today The post 5 Penny Stocks To Buy For Under $5 appeared first on Penny Stocks to Buy, Picks, News and
Lexicon Pharmaceuticals, Inc. (LXRX) CEO Lonnel Coats on Q2 2022 Results - Earnings Call Transcript
11:30pm, Tuesday, 02'nd Aug 2022
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX ) Q2 2022 Earnings Conference Call August 2, 2022 5:00 PM ET Company Participants Mike Kelly - Investor Relations Lonnel Coats - Chief Executive Officer Jeff
Lexicon Pharmaceuticals to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 2, 2022
08:00am, Friday, 29'th Jul 2022
THE WOODLANDS, Texas, July 29, 2022 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will release its second quarter 2022 financial results on Tuesday, August 2, 2022 after the market
Lexicon: Beaten Down Stock, High Risk-Reward Situation Ahead
11:00am, Tuesday, 31'st May 2022
Lexicon has not been lucky with the FDA. However, there are reasons, discussed below, which make me see a special situation here.
